Work

Etanercept treatment to enable successful hepatitis C virus clearance in a patient with rheumatoid arthritis.

Year: 2011

Type: article

Abstract: Arthralgias and the presence of serum rheumatoid factor are common in patients infected with hepatitis C virus (HCV). True rheumatoid arthritis is rarer, but it can limit the ability to cure HCV infection with interferon due to exacerbation of rheumatic disease. In this case study, we report the successful clearance of HCV by using etanercept (Enbrel, Immunex) in combination with pegylated interferon-α (pegIFN-α) and ribavirin in a patient with rheumatoid arthritis who had previously stopped therapy prematurely due to worsening of joint symptoms.

Source: Europe PMC (PubMed Central)

Authors: Alison B Jazwinski, Janet Jezsik, Stacy P Ardoin, Rex M McCallum, Hans L Tillmann

Institutions: Duke University, Duke Medical Center, The Ohio State University

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W201395942

FWCI: 0.744

Cites: 14

Cited by: 9

Related to: 10